SEC Form 4 · accession 0001209191-18-050651
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David L Gollaher
Director
Period of report
Sep 10, 2018
Accepted (ET)
Sep 12, 2018 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.15 | Sep 10, 2018 | A | 20,000 | A | — | Sep 9, 2028 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F11/3rd of the total number of shares subject to the award shall vest on September 10, 2019 and the remaining 2/3rds of the shares will vest in equal monthly installments over a two year period such that the option is fully vested on September 10, 2021.